BEL bags ₹1,011 crore in fresh defence orders, boosting order book

BEL secured orders worth ₹1,011 crore since Feb 25, 2026, including communication equipment, radar systems, and software. BEL reported Q3 revenue of ₹7,122 crore, up 23.7%.

BEL secured orders worth ₹1,011 crore since Feb 25, 2026, including communication equipment, radar systems, and software. BEL reported Q3 revenue of ₹7,122 crore, up 23.7%.

AstraZeneca Pharma India got CDSCO approval to market Durvalumab for unresectable hepatocellular carcinoma, expanding its oncology portfolio. Shares closed 0.33% higher at ₹8,403.

India Glycols Ltd announces a ₹7.5 interim dividend per share for FY 2025-26. Shares of India Glycols Ltd ended marginally lower on Tuesday, March 17, by 0.51% at 853.50 on the NSE.

Aurobindo Pharma announced that the US FDA classified its subsidiary Eugia Pharma’s unit-II in Bhiwadi as ‘Official Action Indicated’ after inspection. No business impact is expected. Shares of the company closed 0.80% up at ₹1,289.80 ahead of the announcement on…

Tech Mahindra London will acquire 20% of Tech Mahindra Arabia from Midad for SAR 83.7M. Expected by July 15, 2026, Tech Mahindra will hold 100% of Tech Mahindra Arabia.

Dow Jones Today | US Stock Market LIVE Updates: US stock futures moved lower on Tuesday (March 17) as crude oil prices climbed again, while investors evaluated US President Donald Trump’s appeal for allied nations to assist in safeguarding maritime…

Power Finance Corporation has approved a ₹1.6 lakh crore borrowing plan for FY27 and announced a fourth interim dividend for FY26, with March 23 set as the record date.
Nikunj Doshi, Managing Partner & CIO-PMS at Bay Capital Investments Advisors, says rising crude prices and global uncertainty are key risks, but markets tend to recover over time. He advises gradual accumulation during corrections, with a long-term positive view on…

Closing Bell: Indian markets ended higher in a volatile session, extending gains for a second day, as midcaps outperformed and market breadth improved, with auto stocks and select heavyweights leading the advance.
Jyoti Gupta, Senior Research Analyst at Nirmal Bang Institutional Equities, remains positive on defence, citing strong order books and execution visibility despite rich valuations, with picks like HAL and BEL. On cement, she sees limited gas impact but rising pet…